Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Position Boosted by New Republic Capital LLC

New Republic Capital LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 568 shares of the medical equipment provider’s stock after buying an additional 147 shares during the period. New Republic Capital LLC’s holdings in Intuitive Surgical were worth $296,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at $82,517,000. Exome Asset Management LLC raised its position in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares during the period. Sycomore Asset Management lifted its stake in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its position in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,940 shares of company stock valued at $3,346,964 in the last quarter. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $595.70 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a market capitalization of $212.18 billion, a P/E ratio of 92.93, a P/E/G ratio of 5.67 and a beta of 1.39. The company has a 50-day simple moving average of $554.85 and a 200-day simple moving average of $514.80.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Barclays increased their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. UBS Group increased their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Royal Bank of Canada boosted their target price on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.